Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ponatinib with chemotherapy in pediatric Ph+ ALL
NCT04501614Phase 2Terminated
- Sponsor
- Takeda
- Start
- Feb 2021
- Primary completion
- Dec 2023
- Modality
- Small Molecules
- Countries
- 15
01
Overview
A Phase 2 trial of ponatinib in acute lymphoblastic leukemia (ALL), sponsored by Takeda. Started Feb 2021; status: terminated.
02
Drugs
ponatinib
03
Conditions
acute lymphoblastic leukemia (ALL)
Beyond the preview
Go deeper on NCT04501614.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04501614.